Financial insights of BIOF

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Revenues	-	0	-	-
General and administrative	350,577	431,134	338,098	236,981
Research and development	485,677	471,470	350,707	410,805
Total operating expenses	836,254	902,604	688,805	647,786
Loss from operations	-836,254	-902,604	-688,805	-647,786
Interest expense - other	-	-	-	206
Interest expense - related party	-	-	-	3,429
Gain (loss) on extinguishment of debt	-	-	-	2,417,502
Grants income	420,030	0	444,970	100,000
Interest expense - related party-Related Party	6,328	18,149	-	-
Interest expense - other	5	1	2	-
Total other (income) expense	413,707	-18,148	444,972	2,513,867
Income (loss) before provisions for income taxes	-422,547	-920,752	-243,833	1,866,081
Provisions for income taxes	-	0	-	-
Net income (loss)	-422,547	-920,752	-243,833	1,866,081

Basic	312,167,546	310,047,521	308,459,719	303,143,362
Diluted	312,167,546	310,047,521	308,459,719	316,851,770
Net income (loss) per basic share	-0.001	-0.003	-0.001	0.006
Net income (loss) per share, fully diluted	-0.001	-0.003	-0.001	0.006